Here are relevant reports on : internal-penetration-testing-market
-
Bioprocess Validation Market by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End-User (CDMO, Biotechnology & Pharmaceutical Companies) & Region - Global Forecasts to 2024
The global bioprocess validation market size is projected to reach USD 360 million by 2024, at a CAGR of 14.6%. The prominent players operating in this market are Merck KGaA (Germany), Sartorius Stedim Biotech (Sartorius AG) (France), Pall Corporation (US), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Cobetter Filtration Equipment Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023
The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years. The bioburden testing market is competitive in nature, with the presence of several large and small players. Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), Becton, Dickinson and Company (US), NAMSA (US), Nelson Laboratories, LLC (US), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (US) are some of the leading payers in the bioburden testing market.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Internet of Things (IoT) Testing Market by Testing Type (Functional, Performance, Network, Security, Compatibility, and Usability), Service Type (Professional and Managed), Application Type, and Region - Global Forecast to 2021
The IoT testing market size is estimated to grow from USD 302.9 Million in 2016 to USD 1,378.5 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 35.4%. The major forces driving the IoT testing market include the growing need for Internet Protocol (IP) testing of the increasing number of IoT devices and applications. Moreover, the need for shift left testing of IoT applications and the rising importance of DevOps are also some of the factors which are driving the market.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Cannabis Testing Market Size by Product & Software (Instruments, Consumables, LIMS), Services (Heavy Metal Testing, Microbial Analysis, Potency, Residual Screening), End-User (Cultivators, Laboratories, Research Institutes) & Region - Global Forecast to 2025
The size of global cannabis testing market in terms of revenue was estimated to be worth USD 962 million in 2020 and is poised to reach USD 1,806 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: January 2021
- Price: $ 4950
- TOC Available:
-
Analytical Laboratory Services Market by Public Health Organization, - by types of services (Stability, Raw Material, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring, Bioanalytical Testing) - Forecast to 2021
The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period. The overall analytical laboratory services market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS, CLIA, ELISA, PCR), End User (Independent & Reference Laboratories, Hospital Laboratories) (2022 - 2026)
The global esoteric testing market is projected to reach USD 36.3 billion by 2026, at a CAGR of 11.6% during the forecast period. The global esoteric testing market is consolidated. The prominent players operating in this market include Labcorp (US), Quest Diagnostics (US) and OPKO Health Inc. (US).
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
CT/NG Testing Market by Product (Assays, Kits & Analyzers), Test Type (Laboratory, Point-of-care Testing), Technology (INAAT, PCR, Immunodiagnostics), End User (Diagnostic Labs, Hospitals & Clinics) & Region - Global Forecast to 2028
The global CT/NG testing market in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.7 billion by 2028, growing at a CAGR of 8.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Elemental Analysis Market by Type (Organic, Inorganic), Technology (Destructive (ICP-AES, ICP-MS), Nondestructive (XRD, OES)), Application (Life Sciences, Food and Beverage Testing, Environment Testing) - Analysis & Global Forecasts to 2020
The elemental analysis market is segmented on the basis of types, technologies, applications and regions. New international GMP and GDP certification ‘EXCiPACT’ for pharmaceutical excipients (North America & Europe), growing food safety concerns, increasing life science R&D spending, increasing use of X-ray fluorescence in medical research, and rise in use of Atomic Absorption Spectroscopy (AAS) to aid the drug safety process are major factors driving this market. In addition, the elemental analysis market has witnessed various technological advancements to meet the needs of biotechnology and biopharmaceutical companies; food and beverage, chemical, semiconductor industries; and environmental testing. The elemental analysis market is expected to reach $6.213 Billion in 2020 from $4.584 Billion in 2015, growing at a CAGR of 6.3%.
- Published: June 2015
- Price: $ 4950
- TOC Available:
-
Fire Testing Market by Service Type (Testing, Inspection, and Certification), Sourcing Type (In-house and Outsourced), Application (Consumer Goods & Retail, Chemicals, Construction & Infrastructure, Mining) Region - Global Forecast till 2024
The global fire testing market size was valued at USD 6.3 billion in 2019 and is projected to reach USD 8.6 billion by 2024; it is expected to grow at a CAGR of 6.4% during the forecast period. The key market players in the market are Intertek (UK), TUV SUD (Germany), IBM (US), SGS Group (Switzerland), Bureau Veritas SA (France), UL LLC (US), DEKRA SE (Germany), QIMA (Hong Kong), Applus+ (Spain), United Technologies (US), Element Materials Technology (UK), and International Fire Consultants Group (UK).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
